Pari Homepage

Results will be updated as you type

For Doctors
  • PARI INT
  • Search
Sort by
Relevance
Title
Date
Content type
Page (150)
Products (20)
Product category
Nebuliser and Year Packs (13)
Clinic and Surgery (3)
VORTEX (3)
Nose and Nasal Sinuses (1)
Searched for year.
Found 170 results in 10 milliseconds.
Results per page:
  • PEP therapy and PEP systems – What is it and what are the benefits?

    Page  |   14.10.2020  |   17% Relevance
    airway diseases such as asthma, COPD, cystic fibrosis (CF) and primary ciliary dyskinesia (PCD) for 20 years. NOTE: The information in this blog post is not a treatment...
    Read more
  • PARI Year Packs

    Page  |   17.12.2018  |   33% Relevance
    YEAR PACKS Do you want to ensure an effective inhalation therapy for the long-term? Then you should replace the nebuliser, connection tubing, air filter and mouthpiece yearly. With...
    Read more
  • PARI Nebuliser and YEAR PACKS

    Page  |   17.12.2018  |   33% Relevance
    Nebulisers and Year Packs PARI has nebulisers specifically adapted for your needs. Moreover, you will be on the safe side with the Year Packs for once-a-year parts replacement....
    Read more
  • PARI LC SPRINT Family

    Page  |   17.12.2018  |   29% Relevance
    Nebuliser for the nasal sinuses PARI LC SPRINT SINUS Nebuliser Users For adults and children from 6 years of age for the treatment of the nasal sinuses. Configuration PARI LC...
    Read more
  • PARI Image Download

    Page  |   09.07.2020  |   31% Relevance
    Download PARI Year Packs PARI Year Pack product images PARI BOY Compact2 Year Pack Item No.: 022G3511 251 kb Download PARI BOY Sinus2 Year Pack Item No.: 023G3811 306 kb Download...
    Read more
  • No greater joy than finding someone you love, regardless if healthy or sick

    Page  |   05.11.2019  |   14% Relevance
    Categories Cystic Fibrosis Testimonials Barbara Hänni has been married to her husband, Markus, for 10 years and they have two daughters. But Markus has the genetic disorder cystic...
    Read more
  • News-Tuesday-02-October-2018

    Page  |   30.01.2019  |   19% Relevance
    regimens that are not specifically approved for MAC lung disease. The course of treatment is often two years or more and is inadequate for treating the disease in many patients....
    Read more
  • News-Friday-25-June-2021

    Page  |   25.06.2021  |   24% Relevance
    of PARI Pharma GmbH on July 1, 2021. Dr. Martin Knoch is retiring on June 30, 2021, after over 30 years at PARI, where he has presided over the development of the eFlow ®...
    Read more
  • News on the treatment of cystic fibrosis

    Page  |   14.03.2023  |   19% Relevance
    cystic fibrosis The use of CFTR modulators has transformed the treatment of cystic fibrosis in recent years. Patients who are eligible for triple CFTR modulator therapy perceive...
    Read more
  • New drug nebulizer combination products

    Page  |   01.02.2021  |   15% Relevance
    which usually expire 20 years after they are filed. However, as patents are filed relatively early during development, the development time needs to be subtracted from that 20-year...
    Read more
  • «
  • ....
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ....
  • »
  • Portals

  • Physician Portal
  • Press portal
  • eFlow® Technology Partnering
  • Career
  • Legal

  • Imprint
  • Data Protection
  • Cookie Consent
  • Accessibility Statement
  • General Terms and conditions
  • Social Media

  • Instagram
  • Facebook
  • LinkedIn
  • YouTube
  • XING

© 2025 PARI GmbH Spezialisten für effektive Inhalation

PARI Germany